Iambic Therapeutics (IAM) news
Recent news
Iambic Therapeutics opens at $16.15, IPO at $16
AInvest Wire · 6h agoIambic IPO said to end more than five times oversubscribed
Iambic Therapeutics, an AI-driven biotech firm, has reportedly seen its initial public offering (IPO) end more than five times oversubscribed, according to recent market reports. The company, which filed for a U.S. IPO earlier in the year, aimed to raise $150 million through the offering. The…
AInvest Wire · 7h agoIambic Therapeutics shares indicated at $17; IPO price $16
AInvest Wire · 8h agoIambic Therapeutics - Prices IPO of 9,375,000 shares at $16 per share
Iambic Therapeutics (IAM), a San Diego-based biotechnology firm leveraging artificial intelligence in drug discovery, has priced its initial public offering (IPO) at $16 per share, raising $150 million in gross proceeds. The offering includes 9.375 million shares on the Nasdaq Global Select Market,…
AInvest Wire · 1d agoIambic announces pricing of initial public offering
Iambic Therapeutics Inc. has announced the pricing of its initial public offering (IPO), which it filed with the SEC . The San Diego-based biotechnology company, which leverages artificial intelligence for drug discovery, plans to list on Nasdaq . The IPO is expected to raise $159.4 million, with…
AInvest Wire · 1d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.